Dr. Allen (Alexander) Krantz
President & CEO
Advanced Proteome Therapeutics Corporation.
650 Albany Street
To speak to our investor relations, please contact:
To be put on our email list for the latest company news, please send your name, telephone number and email address to firstname.lastname@example.org
If you are an industry professional and would like to learn more about partnering with Advanced Proteome Therapeutics to take advantage of our novel technology, please send an email detailing your requirements to: email@example.com
This website contains historical and forward-looking statements. The forward-looking statements involve risks and uncertainties. Forward looking statements appearing on this website in this presentation represent management's current estimates at the time they were posted and these may change significantly as new information comes to hand. The information contained in this website has been obtained by Advanced Proteome Therapeutics Corporation. from its own records and from other sources believed to be reliable, however no representation or warranty is made as to its accuracy or completeness. Reference should be made to the Company's most recent Annual Report filed with Canadian securities regulatory authorities (and available at www.sedar.com) for a description of the major risk factors.